SA

Sahadot Ali Mir

Active Director Director DIN 11206866
DIN 11206866 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Jul 2025
Shareholding value •••• Premium profile

About Sahadot Ali Mir

Data last updated:

Sahadot Ali Mir is a Director at Alfa Biomed India Private Limited (since 2025), Director at Generic Healthcare Private Limited (since 2025) and Director at Sanzio Lifesciences Private Limited (since 2026). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹135 Cr; the largest is Alfa Biomed India Private Limited at ₹117 Cr (FY 2024).

DIN 11206866
Primary Designation Director
Industry Pharma
First Appointment 23 Jul 2025
Oldest Company Age 16 yrs
Largest company Alfa Biomed India Private Limited · ₹117 Cr (FY 2024)
Combined revenue ₹135 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alfa Biomed India Private Limited U74999PN2016FTC158316
Director23 Jul 20252016₹117 Cr (FY 2024)Active
Generic Healthcare Private Limited U33110PN2010PTC136997
Director23 Jul 20252010₹17.92 Cr (FY 2025)Active
Sanzio Lifesciences Private Limited U21001PN2026PTC256779
Director18 Jun 20262026Active

Directorship timeline

Open interactive timeline →
Sanzio Lifesciences Private Limited
Generic Healthcare Private Limited
Alfa Biomed India Private Limited
Premium access

Shareholding and investment profile for Sahadot Ali Mir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sahadot Ali Mir

Sahadot Ali Mir currently holds 3 directorships: Alfa Biomed India Private Limited (Director, since 23 Jul 2025, revenue ₹117 Cr (FY 2024)); Generic Healthcare Private Limited (Director, since 23 Jul 2025, revenue ₹17.92 Cr (FY 2025)); Sanzio Lifesciences Private Limited (Director, since 18 Jun 2026).

Sahadot Ali Mir was first appointed on 23 Jul 2025 as Director at Alfa Biomed India Private Limited. The most recent appointment on record is 18 Jun 2026 at Sanzio Lifesciences Private Limited.

The 2 current companies of Sahadot Ali Mir that report revenue have a combined latest revenue of ₹135 Cr: Alfa Biomed India Private Limited ₹117 Cr (FY 2024); Generic Healthcare Private Limited ₹17.92 Cr (FY 2025).

The current boards of Sahadot Ali Mir's companies include Aniket Bhalchandra Kulkarni (Alfa Biomed India Private Limited), Anushka Abhijit Bora (Alfa Biomed India Private Limited), Dinesh Chandak (Alfa Biomed India Private Limited), Kiran Sukhdeo Malekar (Alfa Biomed India Private Limited), Krishna Abhijit Bora (Alfa Biomed India Private Limited), Rohit Balkrishna Kulkarni (Alfa Biomed India Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available